TriAltus Bioscience receives patent for in-house system

A local bioscience company has secured a patent for its in-house product.   The U.S Patent and Trademark Office has issued U.S. Patent No 10,759,830 to TriAltus Bioscience for its CLīM affinity tag system, which delivers proteins with ultra-high purity and yield in one step.  The patent covers mutations made to colicin E7, a naturally occurring E.coli protein, making it suitable for use as a novel tag. The technology is based on an ultra-high binding affinity between the engineered E7 protein…
Source: bizjournals.com Health Care News Headlines - Category: Health Management Authors: Source Type: news